The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Small‐intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease
Open accessAbstract
Summary: Background Small‐intestinal bacterial overgrowth (SIBO) is known to be present in patients with cirrhosis, predisposing to various complications. Aim To determine the frequency of SIBO in cirrhotics and correlate with severity of cirrhosis. Methods Small‐intestinal bacterial overgrowth was determined by glucose–hydrogen breath test (GHBT). A basal breath‐hydrogen >20 ppm or a rise by ≥12 ppm above baseline following glucose administration was taken as positive test. Prevalence of SIBO in cirrhotics was compared with healthy controls and correlated with severity of cirrhosis. Results Of the 53 cirrhotics, 26 (49%) had SIBO, compared to one (8%) control (P = 0.010). The prevalence of SIBO increased with severity of cirrhosis (Child–Pugh A 20%, B 52% and C 73%; P = 0.013). On multivariate analysis, SIBO was independently associated with serum bilirubin and ascites. The best cut‐off of serum bilirubin was ≥2 mg/dL [AUROC 0.77 (95% CI 0.64–0.90)] predicting SIBO with sensitivity 65%, specificity 81%, positive predictive value 77%, negative predictive value 71% and accuracy 74%. Patients having combination of ascites and serum bilirubin ≥2 mg/dL had 82% chance, while patients having neither had only 10% chance of having SIBO. Conclusions Small‐intestinal bacterial overgrowth was prevalent in about half of cirrhotics. Its frequency increased with increase in severity of cirrhosis. Ascites and raised serum bilirubin reliably predicted presence of SIBO.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alcohol causes intestinal bacterial overgrowth in humans and bacterial numbers were significantly higher in jejunal aspirates from patients with chronic alcohol abuse compared with controls, with similar findings in patients with alcohol-induced cirrhosis.45”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial translocation (BT) in cirrhosis†
Wiest, R., & Garcia‐Tsao, G. (2005) · Hepatology · doi:10.1002/hep.20632 · Cited by 677
Liu, Q., Duan, Z. P., Ha, D. K., Bengmark, S., Kurtovic, J., & Riordan, S. M. (2004) · Hepatology · doi:10.1002/hep.20194 · Cited by 636
The hepatic venous pressure gradient: Anything worth doing should be done right
Groszmann, R. J., & Wongcharatrawee, S. (2004) · Hepatology · doi:10.1002/hep.20062 · Cited by 530
Use and abuse of hydrogen breath tests
Simrén, M., & Stotzer, P.-O. (2006) · Gut · doi:10.1136/gut.2005.075127 · Cited by 415
Incomplete Absorption of the Carbohydrate in All-Purpose Wheat Flour
Anderson, I. H., Levine, A. S., & Levitt, M. D. (1981) · New England Journal of Medicine · doi:10.1056/nejm198104093041507 · Cited by 378
The diagnosis of small bowel bacterial overgrowth
Corazza, G. R., Menozzi, M. G., Strocchi, A., Rasciti, L., Vaira, D., Lecchini, R., Avanzini, P., Chezzi, C., & Gasbarrini, A. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90818-l · Cited by 351
Jejunal microflora in patients with chronic alcohol abuse.
Jc, B., Bode, C., Heidelbach, R., Hk, D., & Ga, M. (1984) · PubMed · Cited by 303
Breath hydrogen testing in bacterial overgrowth of the small intestine
Kerlin, P., & Wong, L. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90173-4 · Cited by 273
Bauer, T., Steinbrückner, B., Brinkmann, F., Ditzen, A. K., Schwacha, H., Aponte, J. J., Pelz, K., Kist, M., & Blum, H. E. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04668.x · Cited by 266
Chang, C., Chen, G., Lien, H., & Yeh, H. (1998) · Hepatology · doi:10.1002/hep.510280504 · Cited by 261
Research works printed but not linked: 1
- Hamilton LH, 1998, Breath Tests and Gastroenterology, 48
Cited by
Sorted by citations
The gut microbiota and host health: a new clinical frontier
Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D. A., Hirschfield, G. M., Hold, G., Quraishi, M. N., Kinross, J., Smidt, H., Tuohy, K. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309990 · Cited by 2,302
“45 The degree of over-growth correlates with the severity of cirrhosis.”
BackgroundCharacterization of fecal microbial communities in patients with liver cirrhosis
Chen, Y., Yang, F., Lu, H., Wang, B., Chen, Y., Lei, D., Wang, Y., Zhu, B., & Li, L. (2011) · Hepatology · doi:10.1002/hep.24423 · Cited by 1,038
Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013
Jalan, R., Fernandez, J., Wiest, R., Schnabl, B., Moreau, R., Angeli, P., Stadlbauer, V., Gustot, T., Bernardi, M., Canton, R., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.024 · Cited by 906
Pathological bacterial translocation in liver cirrhosis
Wiest, R., Lawson, M. A., & Geuking, M. B. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.044 · Cited by 826
Small intestinal bacterial overgrowth syndrome
Bures, J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i24.2978 · Cited by 620
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease
Fouts, D. E., Torralba, M., Nelson, K. E., Brenner, D. A., & Schnabl, B. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.019 · Cited by 311
The intestinal microbiota and chronic disorders of the gut
Dupont, A. W., & DuPont, H. L. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.133 · Cited by 310
Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
Sangro, B., Chan, S. L., Meyer, T., Reig, M., El-Khoueiry, A. B., & Galle, P. R. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.021 · Cited by 299
Microbiota and the gut-liver axis: Bacterial translocation, inflammation and infection in cirrhosis
Giannelli, V. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i45.16795 · Cited by 242
How to Interpret Hydrogen Breath Tests
Ghoshal, U. C. (2011) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2011.17.3.312 · Cited by 232
Probiotics Prevent Hepatic Encephalopathy in Patients with Cirrhosis: A Randomized Controlled Trial
Lunia, M. K., Sharma, B. C., Sharma, P., Sachdeva, S., & Srivastava, S. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.11.006 · Cited by 218
Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia
Connell, E., Le Gall, G., Pontifex, M. G., Sami, S., Cryan, J. F., Clarke, G., Müller, M., & Vauzour, D. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00548-6 · Cited by 208
Gupta, A., Dhiman, R. K., Kumari, S., Rana, S., Agarwal, R., Duseja, A., & Chawla, Y. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.017 · Cited by 202
Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance
Sachdev, A. H., & Pimentel, M. (2013) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622313496126 · Cited by 187
Gut Microbiota: Its Role in Hepatic Encephalopathy
Rai, R., Saraswat, V. A., & Dhiman, R. K. (2014) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2014.12.003 · Cited by 180
Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test
Erdogan, A., Rao, S. S. C., Gulley, D., Jacobs, C. E., Lee, Y. Y., & Badger, C. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12516 · Cited by 163
Wenniger, L. J. M. D. B., & Beuers, U. H. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.03.015 · Cited by 162
Altered Microbiome in Patients With Cirrhosis and Complications
Acharya, C., & Bajaj, J. S. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.08.008 · Cited by 164
Ponziani, F. R., Zocco, M. A., Cerrito, L., Gasbarrini, A., & Pompili, M. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1481747 · Cited by 139
Gastrointestinal dysfunction in liver cirrhosis
Kalaitzakis, E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i40.14686 · Cited by 127
Metagenomics of the Human Body
Nelson, K. E. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7089-3 · Cited by 118
Annavajhala, M. K., Gomez‐Simmonds, A., Maćešić, N., Sullivan, S. B., Kress, A., Khan, S. D., Giddins, M. J., Stump, S., Kim, G., Narain, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12633-4 · Cited by 121
Yan, A. W. (2012) · World Journal of Hepatology · doi:10.4254/wjh.v4.i4.110 · Cited by 112
The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease
Hartmann, P., Chen, W., & Schnabl, B. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00402 · Cited by 110
Small Intestinal Bacterial Overgrowth
Quigley, E. M. M., & Abu-Shanab, A. (2010) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.07.007 · Cited by 108
Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases
Park, J. W., Kim, S. E., Lee, N. Y., Kim, J. H., Jung, J.-H., Jang, M.-K., Park, S.-H., Lee, M.-S., Kim, D.-J., Kim, H.-S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010426 · Cited by 110
Gut microbiome and liver disease
Betrapally, N. S., Gillevet, P. M., & Bajaj, J. S. (2016) · Translational research · doi:10.1016/j.trsl.2016.07.005 · Cited by 106
Epidemiology of small intestinal bacterial overgrowth
Efremova, I., Maslennikov, R. V., Poluektova, E. A., Vasilieva, E., Zharikov, Y. O., Suslov, A. V., Letyagina, Y., Kozlov, E. M., Levshina, A., & Ivashkin, V. T. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i22.3400 · Cited by 112
Hanouneh, M. A., Hanouneh, I. A., Hashash, J. G., Law, R. J., Esfeh, J. M., López, R., Hazratjee, N., Smith, T. H., & Zein, N. N. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182506dbb · Cited by 95
Jayakumar, S., & Loomba, R. S. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15314 · Cited by 87
The promise of metabolic phenotyping in gastroenterology and hepatology
Holmes, E. C., Wijeyesekera, A., Taylor-Robinson, S. D., & Nicholson, J. K. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.114 · Cited by 86
Host-Microbiome Interactions in Alcoholic Liver Disease
Chen, P., & Schnabl, B. (2014) · Gut and Liver · doi:10.5009/gnl.2014.8.3.237 · Cited by 76
Malnutrition in cirrhosis: More food for thought
Chapman, B., Sinclair, M. J., Gow, P. J., & Testro, A. (2020) · World Journal of Hepatology · doi:10.4254/wjh.v12.i11.883 · Cited by 74
Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis
Maslennikov, R. V., Pavlov, C. S., & Ivashkin, V. T. (2018) · Hepatology International · doi:10.1007/s12072-018-9898-2 · Cited by 74
Shah, A., Shanahan, E. R., Macdonald, G. A., Fletcher, L. M., Ghasemi, P., Morrison, M., Jones, M., & Holtmann, G. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1608832 · Cited by 77
Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis
Ghosh, G., & Jesudian, A. B. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.08.006 · Cited by 71
The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders
Losurdo, G., D’Abramo, F. S., Indellicati, G., Lillo, C., Ierardi, E., & Leo, A. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103531 · Cited by 71
The gut–liver axis in immune remodeling of hepatic cirrhosis
Guan, H., Zhang, X., Kuang, M., & Yu, J. Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.946628 · Cited by 73
Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver
Lutz, P. L. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.304 · Cited by 67
Gut microbiota and hepatic encephalopathy
Dhiman, R. K. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-013-9388-0 · Cited by 58
Targeting Dysbiosis for the Treatment of Liver Disease
Anand, G. S., Zarrinpar, A., & Loomba, R. S. (2016) · Seminars in Liver Disease · doi:10.1055/s-0035-1571276 · Cited by 59
Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota
Garcovich, M. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i46.6693 · Cited by 56
Sroka, N., Rydzewska–Rosołowska, A., Kakareko, K., Rosołowski, M., Głowińska, I., & Hryszko, T. (2022) · Nutrients · doi:10.3390/nu15010090 · Cited by 63
Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability
van Vlerken, L. G., Huisman, E. J., van Hoek, B., Renooij, W., de Rooij, F. W. M., Siersema, P. D., & van Erpecum, K. J. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02643.x · Cited by 53
Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis
Campion, D., Giovo, I., Ponzo, P., Saracco, G. M., Balzola, F. A., & Alessandria, C. (2019) · World Journal of Hepatology · doi:10.4254/wjh.v11.i6.489 · Cited by 57
Diagnosis and treatment of small intestinal bacterial overgrowth
Ponziani, F. R., Gerardi, V., & Gasbarrini, A. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1110017 · Cited by 52
Hassouneh, R., & Bajaj, J. S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020330 · Cited by 53
Tran, C. D., Grice, D. M., Wade, B., Kerr, C. A., Bauer, D. C., Li, D., & Hannan, G. N. (2015) · Future Microbiology · doi:10.2217/fmb.15.54 · Cited by 48
The Role of the Human Microbiome in Chemical Toxicity
Koontz, J. M., Dancy, B. C. R., Horton, C. L., Stallings, J. D., DiVito, V. T., & Lewis, J. A. (2019) · International Journal of Toxicology · doi:10.1177/1091581819849833 · Cited by 48
Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
Nishikawa, H., Enomoto, H., Nishiguchi, S., & Iijima, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155254 · Cited by 49
Pande, C., Kumar, A., & Sarin, S. K. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283537d61 · Cited by 47
Self-citationPatients With Irritable Bowel Syndrome Exhale More Hydrogen Than Healthy Subjects in Fasting State
Kumar, S., Misra, A., & Ghoshal, U. C. (2010) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2010.16.3.299 · Cited by 47
Zhang, N., Gou, Y., Liang, S., Chen, N., Liu, Y., He, Q., & Zhang, J. (2021) · Journal of Immunology Research · doi:10.1155/2021/4973589 · Cited by 46
The Intestinal Microbiome and the Liver Transplant Recipient
Doycheva, I., Leise, M. D., & Watt, K. D. S. (2015) · Transplantation · doi:10.1097/tp.0000000000001008 · Cited by 45
Korterink, J., Benninga, M. A., van Wering, H. M., & Deckers‐Kocken, J. M. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000634 · Cited by 45
Lee, S. H., Kim, K.-N., Kim, K.-M., & Joo, N. (2015) · Yonsei Medical Journal · doi:10.3349/ymj.2016.57.1.146 · Cited by 44
Xu, J., Ma, R., Chen, L.-F., Zhao, L., Chen, K., & Zhang, R. (2014) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(14)60280-0 · Cited by 44
Jung, J. H., Kim, S. E., Suk, K. T., & Kim, D. J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.913842 · Cited by 42
Kaufmann, B. K., Seyfried, N., Hartmann, D., & Hartmann, P. (2023) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00017.2023 · Cited by 40
Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis.
Zhang, Y., Feng, Y., Cao, B., & Tian, Q. (2015) · PubMed Central · Cited by 35
Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis
Liu, Y., Jin, Y., Li, J., Zhao, L., Li, Z., Xu, J., Zhao, F., Feng, J., Chen, H., Fang, C., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00470 · Cited by 35
Brechmann, T., Sperlbaum, A., & Schmiegel, W. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i5.842 · Cited by 34
The enteric microbiome in hepatobiliary health and disease
Tabibian, J. H., Varghese, C., LaRusso, N. F., & O’Hara, S. P. (2015) · Liver International · doi:10.1111/liv.13009 · Cited by 33
Romeiro, F. G., Yamashiro, F. D. S., Américo, M. F., Corá, L. A., Silva, G. F., Miranda, J. R. D. A., & Caramori, C. A. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-13 · Cited by 31
Nutrition status and small intestinal bacterial overgrowth in patients with virus-related cirrhosis.
Yao, J., Chang, L., Yuan, L., & Duan, Z. (2016) · PubMed · doi:10.6133/apjcn.2016.25.2.06 · Cited by 31
Jacobs, J. P., Dong, T. S., Agopian, V. G., Lagishetty, V., Sundaram, V., Noureddin, M., Ayoub, W. S., Durazo, F. A., Benhammou, J. N., Enayati, P. J., et al. (2018) · Hepatology Research · doi:10.1111/hepr.13207 · Cited by 31
Манжалій, Е., Moyseyenko, V. O., Кondratiuk, V. Y., Molochek, N., Falalyeyeva, T. M., & Kobyliak, N. M. (2022) · World Journal of Hepatology · doi:10.4254/wjh.v14.i3.634 · Cited by 31
Zhu, J., Qi, X., Yu, H., Yoshida, E. M., Mendez-Sanchez, N., Zhang, X., Wang, R., Deng, H., Li, J., Han, D., et al. (2018) · United European Gastroenterology Journal · doi:10.1177/2050640618773564 · Cited by 28
Zhang, Y., Feng, Y., Cao, B., & Tian, Q. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.55675 · Cited by 27
Lunia, M. K., Sharma, B. C., & Sachdeva, S. (2012) · Hepatology International · doi:10.1007/s12072-012-9360-9 · Cited by 26
Novel prevention strategies for bacterial infections in cirrhosis
Yan, K. G., & García–Tsao, G. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1145663 · Cited by 26
Hydrogen- and Methane-Based Breath Testing and Outcomes in Patients With Heart Failure
Mollar, A., Villanueva, M. P., Núñez, E., Carratalá, A., Mora, F., Bayés‐Genís, A., Mínguez, M., Marrachelli, V. G., Monleón, D., Navarro, D., et al. (2018) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2018.10.004 · Cited by 26
Fialho, A., Fialho, A. B. C., Kochhar, G. S., Schenone, A. L., Thota, P. N., McCullough, A. J., & Shen, B. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4828-z · Cited by 26
Is small intestinal bacterial overgrowth a cause of hyperdynamic circulation in cirrhosis?
Maslennikov, R. V., Pavlov, C. S., & Ivashkin, V. T. (2019) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2019.18551 · Cited by 23
Therrien, A., Bouchard, S., Sidani, S., & Bouin, M. (2016) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2016/7424831 · Cited by 21
New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease
Hartmann, P., & Schnabl, B. (2021) · Seminars in Liver Disease · doi:10.1055/s-0040-1719174 · Cited by 22
Nonalcoholic fatty liver disease, diet and gut microbiota
Finelli, C., & Tarantino, G. (2014) · Europe PMC (PubMed Central) · doi:10.17877/de290r-15828 · Cited by 20
RetractedRole of alcohol in the development and progression of hepatocellular carcinoma
McKillop, I. H., Schrum, L. W., & Thompson, K. J. (2015) · Hepatic Oncology · doi:10.2217/hep.15.40 · Cited by 18
Gómez‐Hurtado, I., Zapater, P., Portune, K. J., Juanola, O., Fernández‐Iglesias, A., González-Navajas, J. M., Gracia‐Sancho, J., Sanz, Y., & Francés, R. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1709-y · Cited by 18
Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis
Li, Y., Huang, J., & Peng, M. (2020) · BioMed Research International · doi:10.1155/2020/3743962 · Cited by 17
Liu, Z., Zhu, S., He, M., Li, M., Wei, H., Zhang, L., Sun, Q., Jia, Q., Hu, N., Fang, Y., et al. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002294 · Cited by 15
Shamseya, M. M., & Madkour, M. A. (2015) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2015.09.002 · Cited by 15
Small Intestinal Bacterial Overgrowth Is Associated with Poor Prognosis in Cirrhosis
Efremova, I., Maslennikov, R. V., Alieva, A. M., Poluektova, E., & Ivashkin, V. T. (2023) · Microorganisms · doi:10.3390/microorganisms11041017 · Cited by 13
Modulating the gut–liver axis and the pivotal role of the faecal microbiome in cirrhosis
Woodhouse, C., Singanayagam, A., & Patel, V. (2020) · Clinical Medicine · doi:10.7861/clinmed.2020-0676 · Cited by 12
Microbiome and gut-liver interactions: From mechanisms to therapies
Anis, M. A., Shahid, Y., Majeed, A. A., & Abid, S. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i40.111409 · Cited by 12
Shah, A., Spannenburg, L., Thite, P., Morrison, M., Fairlie, T., Koloski, N. A., Kashyap, P., Pimentel, M., Rezaie, A. R., Gores, G. J., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.103024 · Cited by 12
Small Intestinal Bacterial Overgrowth (SIBO)
Roland, C. (2014) · Journal of Gastrointestinal & Digestive System · doi:10.4172/2161-069x.1000225 · Cited by 11
Probiotics for the Treatment of Liver Disease
Punzalan, C., & Qamar, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00040-9 · Cited by 10
Fragkos, K. C., Bouroncle, M. C. P., Kumar, S., Caselton, L., Menys, A., Bainbridge, A. P., Taylor, S. A., Torrealdea, F. J., Kumagai, T., Caro, S. D., et al. (2020) · Nutrients · doi:10.3390/nu12072151 · Cited by 10
Gastrointestinal Dysfunction in Chronic Liver Disease
Nguyen, D. H. N. Q. (2015) · Journal of Gastrointestinal & Digestive System · doi:10.4172/2161-069x.1000257 · Cited by 10
Zhang, J., Ren, F., Liu, P., Zhang, H.-K., Zhu, H., Feng, Z., Zhang, X., Wang, B., Liu, X., Zhang, X., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i46.8217 · Cited by 10
Is periodontitis a risk factor for infections in cirrhotic patients?
Profio, B. D., Villar, C. C., Saraiva, L. M., Ortega, K. L., & Pannuti, C. M. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.06.022 · Cited by 9
Antibiotics in Chronic Liver Disease and Their Effects on Gut Microbiota
Méndez‐Sánchez, N., Coronel-Castillo, C. E., Córdova‐Gallardo, J., & Qi, X. (2023) · Antibiotics · doi:10.3390/antibiotics12101475 · Cited by 8
Sturm, L., Gahm, C., Schultheiß, M., Reincke, M., Huber, J. P., Boettler, T., Thimme, R., & Bettinger, D. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000178 · Cited by 8
Sturm, L., Hirose, M., Stolz, L., Schultheiß, M., Zoldan, K., Reincke, M., Huber, J. P., Kaeser, R., Boettler, T., Thimme, R., et al. (2023) · mBio · doi:10.1128/mbio.00492-23 · Cited by 8
The prevalence and impact of small intestine bacterial overgrowth in biliary atresia patients
Wu, J., Tseng, P., Chang, H., Chiang, C., Lin, W., Hsu, W., & Chang, M. (2023) · Pediatric Research · doi:10.1038/s41390-023-02818-5 · Cited by 6
Small Intestinal Bacterial Overgrowth and Pediatric Obesity—A Systematic Review
Koller, A. M., Săsăran, M. O., & Mărginean, C. O. (2025) · Nutrients · doi:10.3390/nu17091499 · Cited by 5
Mustafa, F., Noor, R., Murtaza, A., Kanwal, W., Kanwal, F., Kaleem, T., Munir, F., Umar, R. A. B., Taib, W. R. W., Krishnasamy, S., et al. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128373584250407134451 · Cited by 5
Liu, M., Wang, P., Zhao, M., & Liu, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166165 · Cited by 5
Zhang, J., Zao, X., Zhang, J., Guo, Z., Jin, Q., Chen, G., Gan, D., Du, H., & Ye, Y. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109627 · Cited by 5
Metadata
- Authors
- PANDE, C., KUMAR, A., & SARIN, S. K.
- Affiliations
- Jawaharlal Nehru University (IN)
- Corresponding author
- SARIN, S. K.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2009-05-21
- Volume
- 29
- Issue
- 12
- Pages
- 1273-1281
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2011658871
- Cited by
- 152
- References
- 30
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 4 · 2023: 9 · 2022: 11 · 2021: 6 · 2020: 8 · 2019: 8 · 2018: 13 · 2017: 12 · 2016: 11 · 2015: 19 · 2014: 11 · 2013: 7 · 2012: 10
- FWCI
- 4.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Alimentary Pharmacology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- small intestinal bacterial overgrowth, liver cirrhosis, Child-Pugh score, glucose hydrogen breath test, serum bilirubin, ascites, SIBO prevalence, diagnostic prediction
- MeSH terms
- Adult, Bacteria, Bacterial Infections, Breath Tests, Humans, Intestinal Diseases, Liver Cirrhosis, Male, Middle Aged, Severity of Illness Index, Statistics as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review